1040-D Identification of four clinically-relevant immunomodulatory programs shared across nearly all glioma-associated myeloid cells by Tyler E Miller, Mario Suva, Zeyu Chen, Chadi El Farran, Charles Couturier, Joshua D’Antonio, Alex Shalek, Kevin Petrecca, Bradley Bernstein